SEC 13F Intelligence

Dekabank Deutsche Girozentrale / GILD

Dekabank Deutsche Girozentrale’s Gilead Sciences Inc Position

Does Dekabank Deutsche Girozentrale own Gilead Sciences Inc (GILD)? Yes — 2.04M shares worth $286M (+0.47% of its 13F portfolio) as of Q1 2026.

Position Value
$286M
Q1 2026
Shares
2.04M
% of Portfolio
+0.47%
Quarters Held
29
currently held

Position History GILD

Reported value by quarter
Q4 ’18: $48MQ4 ’18Q1 ’19: $66MQ2 ’19: $77MQ3 ’19: $74MQ4 ’19: $55MQ4 ’19Q1 ’20: $58MQ2 ’20: $61MQ3 ’20: $105MQ1 ’21: $97MQ1 ’21Q2 ’21: $98MQ3 ’21: $106MQ4 ’21: $108MQ1 ’22: $112MQ1 ’22Q2 ’22: $119MQ3 ’22: $135MQ4 ’22: $166MQ1 ’23: $163MQ1 ’23Q2 ’23: $157MQ3 ’23: $157MQ4 ’23: $177MQ1 ’24: $151MQ1 ’24Q2 ’24: $196MQ3 ’24: $170MQ4 ’24: $190MQ1 ’25: $229MQ1 ’25Q2 ’25: $226MQ3 ’25: $229MQ4 ’25: $147MQ1 ’26: $286MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.04M$286M+0.47%
Q4 20252.04M$147M+0.25%
Q3 20252.04M$229M+0.38%
Q2 20252.04M$226M+0.40%
Q1 20252.06M$229M+0.45%
Q4 20242.04M$190M+0.35%
Q3 20242.04M$170M+0.31%
Q2 20242.83M$196M+0.35%
Q1 20242.06M$151M+0.28%
Q4 20232.20M$177M+0.36%
Q3 20232.09M$157M+0.36%
Q2 20232.06M$157M+0.35%
Q1 20232.00M$163M+0.41%
Q4 20221.96M$166M+0.44%
Q3 20222.14M$135M+0.40%
Q2 20221.91M$119M+0.35%
Q1 20221.86M$112M+0.27%
Q4 20211.46M$108M+0.26%
Q3 20211.50M$106M+0.30%
Q2 20211.46M$98M+0.29%
Q1 20211.47M$97M+0.32%
Q3 20201.68M$105M+0.47%
Q2 2020815.3K$61M+0.39%
Q1 2020758.9K$58M+0.44%
Q4 2019841.8K$55M+0.34%
Q3 20191.18M$74M+0.46%
Q2 20191.14M$77M+0.38%
Q1 2019859.1K$66M+0.39%
Q4 2018754.0K$48M+0.32%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dekabank Deutsche Girozentrale’s full portfolio or all institutional holders of GILD.